| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 3,103,000 | 4,067,000 | 7,119,000 | 7,220,000 | | Cost of Revenue | 2,122,000 | (430,000) | 2,875,000 | 2,769,000 | | | Gross Profit | 981,000 | 4,497,000 | 4,244,000 | 4,451,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 375,000 | 572,000 | 393,000 | 480,000 | | Non Recurring |
-
| 647,000 | 28,000 | (4,000) | | Others |
-
| 2,710,000 |
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 606,000 | 568,000 | 3,823,000 | 3,975,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| (111,000) | 111,000 | | Earnings Before Interest And Taxes | 606,000 | 568,000 | 3,823,000 | 3,975,000 | | Interest Expense | 27,000 | 35,000 | 24,000 | 32,000 | | Income Before Tax | 579,000 | 533,000 | 3,799,000 | 3,943,000 | | Income Tax Expense | 241,000 | 118,000 | 1,546,000 | 1,671,000 | | Minority Interest |
-
| (12,000) | (38,000) | (37,000) | | | | Net Income From Continuing Ops | 380,000 | 448,000 | 2,272,000 | 2,300,000 | | | Non-recurring Events | | Discontinued Operations | (3,000) | (5,000) | (1,000) | (3,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 377,000 | 443,000 | 2,271,000 | 2,297,000 | | Preferred Stock And Other Adjustments | (9,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $368,000 | $443,000 | $2,271,000 | $2,297,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
